AZN Cost of Revenue

AstraZeneca PLC Ordinary Shares · Cost of Revenue

AZN logo

AZN Cost of Revenue

Latest reported$11.12B
AZN Cost of Revenue ($0.00 → $11.12B)
High-resolution chart · PNG

AZN cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
10,633,000,000
10,207,000,000
8,268,000,000
12,391,000,000
12,437,000,000
5,299,000,000
4,921,000,000
4,936,000,000
4,318,000,000
4,126,000,000
4,646,000,000
5,842,000,000
5,261,000,000
5,393,000,000
6,026,000,000
6,389,000,000
5,775,000,000
6,598,000,000
6,419,000,000
5,559,000,000
5,356,000,000
5,193,000,000
4,463,000,000
4,520,000,000
4,456,000,000
0
3,248,000,000
2,031,000,000
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.